A key factor driving the growth of the market is the growing orthopedic conditions and surgical cases. Surgery is required to treat orthopedic cases. Fracture and dislocation of the lower extremity, total and partial hip replacement, and spinal fusions are some of the major orthopedic conditions that require the use of bone growth stimulation devices. Bone growth stimulation devices are used for spinal fusion following cervical and lumbar spine surgeries. These devices deliver low-intensity electrical signals to stimulate the natural bone healing process.
This market research report on the global bone growth stimulation devices market 2019–2023 also provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.
Download the free sample report @ http://bit.ly/37o9mgX
In this report, Technavio highlights the smart applications for external bone growth stimulation devices as one of the key emerging trends in the global bone growth stimulation devices market:
Global bone growth stimulation devices market: Smart applications for external bone growth stimulation devices
Vendors are coming up with smart applications that are integrated with external bone growth stimulation devices. These applications help doctors track the progress of treatment via smartphones updates and helps them to plan follow-up protocols to achieve better outcomes.
“Smart applications also send patients daily reminders about the treatment schedule and duration of treatment. These smart applications provide user guides and other necessary information to patients for better utilization of the device and faster bone healing. Several vendors are providing smart applications for their products. For instance, Orthofix provides the STIM onTrack mobile application for its product offerings, such as Cervical-Stim and Spinal-Stim external bone growth stimulation devices,” says a senior analyst at Technavio for research on infectious and rare diseases.
Comments